Disclosure Of Fair Value Measurement [Text Block]

Bayer AG - Filing #6538644

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
124,877,000 EUR
120,241,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
38,926,000 EUR
112,000,000 EUR
EUR
153,000,000 EUR
18,261,000 EUR
17,233,000 EUR
2,515,000 EUR
531,000,000 EUR
38,773,000 EUR
121,000,000 EUR
13,345,000 EUR
EUR
33,168,000 EUR
1,000,000 EUR
212,000,000 EUR
33,020,000 EUR
18,261,000 EUR
148,000,000 EUR
1,312,000 EUR
2,515,000 EUR
13,057,000 EUR
152,000,000 EUR
152,000,000 EUR
30,523,000 EUR
2,515,000 EUR
3,581,000 EUR
2,000,000 EUR
18,261,000 EUR
30,675,000 EUR
117,000,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.